| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/18/1999 | US5905084 5-HTIF -agonists effective in treating migraine |
| 05/18/1999 | US5905083 Method of treating rheumatoid arthritis |
| 05/18/1999 | US5905071 Glycosylamides of 2-aminoacylamino-2-deoxy sugars |
| 05/18/1999 | US5905070 5--Caboxamido or 5--fluoro!-- 2', 3'--unsaturated or 3'--modified!--pyrimidine nucleosides |
| 05/18/1999 | US5904920 Regulation of systemic immune responses utilizing cytokines and antigens |
| 05/18/1999 | CA1340548C Method for producing native hiv gp160 |
| 05/14/1999 | WO1999023220A1 Suppressor of cytokine signaling |
| 05/14/1999 | WO1999023114A1 Muc-1 derivatives and their use in treating cancer-associated muc-1 mucin-induced immunosuppression |
| 05/14/1999 | WO1999023105A1 Vegi, an inhibitor of angiogenesis and tumor growth |
| 05/14/1999 | WO1999023076A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors |
| 05/14/1999 | WO1999022766A2 Use of anti-il-12 antibodies in transplantation rejection |
| 05/14/1999 | WO1999022764A1 Methods and compositions comprising glycoprotein glycoforms |
| 05/14/1999 | WO1999022762A1 Tolerogenic fragments of natural allergens |
| 05/14/1999 | WO1999022761A1 Conjugate heat shock protein-binding peptides |
| 05/14/1999 | WO1999022734A1 Novel metal complexes |
| 05/14/1999 | WO1999022732A1 Novel metal complexes |
| 05/14/1999 | WO1999022729A1 The use of proteasome inhibitors for treating cancer, inflammation, autoimmune disease, graft rejection and septic shock |
| 05/14/1999 | WO1999007351A3 Indole derivatives and their use as mcp-1 antagonists |
| 05/14/1999 | WO1999001467A3 Therapeutically active compounds with low systemic activity due to reduce half life |
| 05/14/1999 | WO1998052582A9 Non-myeloablative tolerogenic treatment |
| 05/14/1999 | WO1998052549B1 Use of fumaric acid derivatives |
| 05/14/1999 | WO1998033904A3 An antisense oligonucleotide preparation method |
| 05/14/1999 | WO1997035539A3 Arylamino fused pyridines and pyrimidines |
| 05/14/1999 | CA2309175A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors |
| 05/14/1999 | CA2308316A1 Novel metal complexes |
| 05/14/1999 | CA2308299A1 Conjugate heat shock protein-binding peptides |
| 05/14/1999 | CA2308135A1 Novel metal complexes |
| 05/14/1999 | CA2307622A1 Muc-1 derivatives and their use in treating cancer-associated muc-1 mucin-induced immunosuppression |
| 05/14/1999 | CA2307166A1 Methods and compositions comprising glycoprotein glycoforms |
| 05/14/1999 | CA2276685A1 Suppressor of cytokine signaling |
| 05/14/1999 | CA2276420A1 Use of anti-il-12 antibodies in transplantation rejection |
| 05/12/1999 | EP0915086A1 Phenylsulfonamide derivatives |
| 05/12/1999 | EP0914831A2 Biological product for preventive or therapeutic oral administration against canine parvovirosis |
| 05/12/1999 | EP0914778A1 Oral administration of bacteria at a concentration which produces cell-mediated immunity and weight in certain animals |
| 05/12/1999 | EP0914605A1 Molecular model for vla-4 inhibitors |
| 05/12/1999 | EP0914443A2 Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection |
| 05/12/1999 | EP0914435A1 Hybrid interferon compositions and methods of use |
| 05/12/1999 | EP0914434A2 Method for preparing transgenic non-human mammalian organs for transplantation to humans, and nucleotide sequences therefor |
| 05/12/1999 | EP0914430A2 Polynucleotides from human fetal brain encoding secreted proteins |
| 05/12/1999 | EP0914417A2 Human dnase ii |
| 05/12/1999 | EP0914347A2 A multivalent major histocompatibility complex peptide fusion protein for modulating specific t cell function |
| 05/12/1999 | EP0914345A1 Antibodies binding to monocyte chemoattractant protein 1 (mcp-1) receptor (ccr2) |
| 05/12/1999 | EP0914333A1 Peptide derivatives |
| 05/12/1999 | EP0914328A1 STREPTOCOCCUS PNEUMONIAE ALANYL tRNA SYNTHETASE |
| 05/12/1999 | EP0914327A1 NOVEL LysS PROTEINS FROM STREPTOCOCCUS PNEUMONIAE |
| 05/12/1999 | EP0914322A1 New indolyl and benzofuranyl carboxamides as inhibitors of nitric oxide production |
| 05/12/1999 | EP0914163A1 Novel processes implementing selective immune down regulation (sidr) |
| 05/12/1999 | EP0914157A1 Anti-tnf antibodies and methotrexate in the treatment of autoimmune disease |
| 05/12/1999 | EP0914129A1 Use of aspirochlorine or derivatives thereof as immunosuppressive agents |
| 05/12/1999 | EP0914114A1 Methods of treating type i hypersensitivity using monophosphoryl lipid a |
| 05/12/1999 | EP0914111A2 Method for the prevention and treatment of cachexia and anorexia |
| 05/12/1999 | EP0914091A2 Ethene containing solutions and use thereof in methods of therapy or prophylaxis |
| 05/12/1999 | EP0914043A1 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof |
| 05/12/1999 | EP0914041A1 Methods and compositions for suppressing an immune response using major histocompatibility complex (mhc) class ii peptides |
| 05/12/1999 | EP0789710B1 Peptides for anti-allergy treatment |
| 05/12/1999 | EP0754230B1 Agonist antibodies against the flk2/flt3 receptor and uses thereof |
| 05/12/1999 | EP0733067B1 N-terminally chemically modified protein compositions and methods |
| 05/12/1999 | EP0654037B1 Antiretroviral enantiomeric nucleotide analogs |
| 05/12/1999 | CN1216582A Autoantigen and proteins structurally related thereto for use in immunotherapy of autoimmune diseases |
| 05/12/1999 | CN1216551A Novel peptides suitable for use in antigen specific immunosuppressive therapy |
| 05/12/1999 | CN1216544A Novel N-7-heterocyclyl pyrrolo [2,3-D] pyridines and their use |
| 05/12/1999 | CN1216470A DHEA combination therapy |
| 05/12/1999 | CN1043347C 2-heteroaryl-5,11-dihydro-6H-dipyrido [3,2-b: 2',3'-3]-3] [1,4] diazepines and their use in the prevention or treatment of HIV infection |
| 05/12/1999 | CN1043344C New heterocyclic compounds, preparing method, pharmaceutical composition and use |
| 05/11/1999 | US5902824 Phenyldihydrobenzofuranes |
| 05/11/1999 | US5902796 Bioactive factors of aloe vera plants |
| 05/11/1999 | US5902791 Metalloproteinase inhibitors |
| 05/11/1999 | US5902627 Process for the production of alkali-treated yogurt powder possessing an immunological activity |
| 05/11/1999 | US5902585 Methods of inducing T cell unresponsiveness to donor tissue or organ in a recipient with GP39 antagonists |
| 05/11/1999 | US5902584 Antibodies which bind the G-CSF receptor extracelluar domain and methods of treatment |
| 05/11/1999 | CA2122724C Fusion proteins comprising mgf and il-3 |
| 05/11/1999 | CA1340538C Recombinant coccidiosis vaccines |
| 05/06/1999 | WO1999022243A1 148 human secreted proteins |
| 05/06/1999 | WO1999021831A1 Tricyclic compounds as cgmp-pde inhibitors |
| 05/06/1999 | WO1999021576A1 Cd8 as an inhibitor of the cellular immune system |
| 05/06/1999 | WO1999021572A1 Soluble mhc complexes and methods of use thereof |
| 05/06/1999 | WO1999021546A1 N,N-DIETHYLGLYCOLAMIDO ESTER PRODRUGS OF INDOLE sPLA2 INHIBITORS |
| 05/06/1999 | WO1999015493A8 9,10-dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors |
| 05/06/1999 | EP0913157A1 A new composite vaccine which contains antigen, antibody and recombinant dna and its preparing method |
| 05/06/1999 | EP0912895A1 Method for monitoring t-cell reactivity |
| 05/06/1999 | EP0912741A2 T-cell selective interleukin-4 agonists |
| 05/06/1999 | EP0912740A1 Rantes homolog from prostate |
| 05/06/1999 | EP0912735A2 Secreted proteins and polynucleotides encoding them |
| 05/06/1999 | EP0912723A1 Highly productive packaging lines |
| 05/06/1999 | EP0912607A2 Vaccines comprising synthetic genes |
| 05/06/1999 | EP0912601A1 Suppression of immune response via inhibition of cathepsin s |
| 05/06/1999 | EP0912571A2 Naphthyridines which affect il-4 and g-csf |
| 05/06/1999 | EP0912545A1 Hydroxamic acid based collagenase inhibitors |
| 05/06/1999 | EP0912521A1 Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf) |
| 05/06/1999 | EP0912505A1 Il-8 receptor antagonists |
| 05/06/1999 | EP0912198A1 Immunoliposomes that optimize internalization into target cells |
| 05/06/1999 | EP0912085A1 Precise efficacy assay methods for active agents including chemotherapeutic agents |
| 05/06/1999 | EP0750607B1 2-(aminoalkoxy)phenylalkylamines with antiinflammatory activity |
| 05/06/1999 | EP0742721B1 Methods of prolonged suppression of humoral immunity |
| 05/06/1999 | EP0589004B1 Process for the determination of peptides corresponding to immunologically important epitopes of hcv |
| 05/06/1999 | EP0570519B1 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| 05/06/1999 | CA2309135A1 N,n-diethylglycolamido ester prodrugs of indole spla2 inhibitors |
| 05/06/1999 | CA2308463A1 Cd8 as an inhibitor of the cellular immune system |
| 05/06/1999 | CA2307320A1 148 human secreted proteins |
| 05/06/1999 | CA2307178A1 Soluble mhc complexes and methods of use thereof |